DIAGNOSTICS
Biomarkers Beyond Our Wildest Dreams
04/02/2019 | Luke Turner
Different glycosylation patterns in patients with idiopathic REM sleep behavior disorder could predict the future onset of neurodegenerative disease
DIAGNOSTICS
Improving Our Early Warning System for AML
04/15/2019 | Amanda Winters
The gold standard for monitoring acute myeloid leukemia relapse after bone marrow transplant is chimerism testing – but is it sensitive enough?
INSIDE THE LAB
Open to the Future
04/15/2019 | Jane Rendall
If artificial intelligence is to make inroads into diagnostic medicine, we must embrace a new standard of openness and interoperability
DIAGNOSTICS
Out With the Old
04/15/2019 | Luke Turner
Existing tests for rapid diagnosis of TB are costly and insufficient – but second-generation assays with improved sensitivity could be the answer
 
The Power List 2019

Do you know any trailblazers working at the cutting edge of pathology or laboratory medicine? Nominate them using the link below and they could appear in The Pathologist’s 2019 Power List!

Nominate Now
 
Tweet of the Week

On April 14th we joined with many healthcare professionals to celebrate Pathologists’ Assistant Day. Take a look at our favorite tweet in appreciation of the great contribution that PAs make to patients, pathologists, and the entire profession.

Click here
 
Passionate. Driven. Impactful.

The Translational Scientist sits at the leading edge of bench-to-bedside research, celebrating translation today – and exploring the inside track on the innovations set to revolutionize tomorrow...

Read the Newsletter
 
Product Profiles
High-performance molecular tumor profiling solution for difficult FFPE samples

Understanding the genetic makeup of tumor specimens can help to identify patients in more aggressive states of the disease. Paragon Genomics’ CleanPlex® OncoZoom® Cancer Hotspot Panel provides the highest coverage uniformity from FFPE samples, allowing efficient use of sequencing reads and accurate variant detection.

Read more
Next-day assessment of hereditary cancer risk using a targeted NGS panel

New guidelines now recommend genetic testing to determine hereditary risk for all breast cancer patients. To ensure ease of use and reduce turn-around time in laboratory setting, Paragon Genomics offers CleanPlex® Hereditary Cancer Panel, an amplicon-based NGS assay that can be performed in just 3 hours, allowing next-day report generation.

Read more
 
Special Promotions
TSO500 Early Access

Leading European cancer centers evaluated a new assay which enables comprehensive genomic profiling (CGP) using next-generation sequencing (NGS). Read more about how TruSight™ Oncology 500 is enabling CGP for every laboratory.

Read more
Here’s How Top Clinical Labs Do Blood Collection Differently

It’s a new age of precise, patient-centered healthcare. More convenient blood collection is the missing link that can unlock the full potential of innovation. Download your comprehensive report and explore case studies, guidelines, and scientific resources to prepare for a smarter future.

Download the ebook
The future is now for NGS and pathology. Are you ready?

Join Agilent as we combine our Genomics Solutions with Dako Pathology on the new frontier of cancer pathology. Learn best wet-lab practices, basics of data analysis, and the impact of our clinical-grade draft reports on precision medicine.

Access our NGS eSeminar Series, resources, and experts
 
Upcoming Events

Be it a large congress at a huge venue or an expert meeting that fits around a table, these events are a fantastic way to network and educate yourself on the latest developments in the laboratory medicine industry – so why not take a look at our list of upcoming events?

More information